User profiles for Graham S. Cooke

Graham Cooke

Imperial College
Verified email at imperial.ac.uk
Cited by 47347

[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses

…, PW Horby, S Ijaz, S Khoo, A Law, MR Lewis, S Liggi… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …

The global burden of cancer 2013

…, SG Sepanlou, S Nolte, S Patten, S Weichenthal… - JAMA …, 2015 - jamanetwork.com
Importance Cancer is among the leading causes of death worldwide. Current estimates of
cancer burden in individual countries and regions are necessary to inform local cancer control …

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013 …

…, MS Coggeshall, V Colistro, SM Colquhoun, GS Cooke… - The Lancet, 2015 - thelancet.com
Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together
all available epidemiological data using a coherent measurement framework, standardised …

[PDF][PDF] Global distribution and prevalence of hepatitis C virus genotypes

…, I Humphreys, A Flaxman, A Brown, GS Cooke… - …, 2015 - Wiley Online Library
Hepatitis C virus (HCV) exhibits high genetic diversity, characterized by regional variations
in genotype prevalence. This poses a challenge to the improved development of vaccines …

The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

…, ST Wiersma, M Younis, C Yu, MES Zaki, GS Cooke - The Lancet, 2016 - thelancet.com
Background With recent improvements in vaccines and treatments against viral hepatitis, an
improved understanding of the burden of viral hepatitis is needed to inform global …

[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …

…, WS Barclay, D Bogaert, M Chand, GS Cooke… - The Lancet …, 2021 - thelancet.com
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

Genetics of susceptibitlity to human infectious disease

GS Cooke, AVS Hill - Nature Reviews Genetics, 2001 - nature.com
Before Robert Koch's work in the late nineteenth century, diseases such as tuberculosis and
leprosy were widely believed to be inherited disorders. Heritability of susceptibility to …

[HTML][HTML] Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study

…, C Roufosse, AG Nicholson, J Weir, GS Cooke… - The Lancet …, 2020 - thelancet.com
Background Severe COVID-19 has a high mortality rate. Comprehensive pathological
descriptions of COVID-19 are scarce and limited in scope. We aimed to describe the …

Technologies for global health

…, A Blakemore, AMJ Bull, J Car, L Conteh, GS Cooke… - The Lancet, 2012 - thelancet.com
Availability of health technology is inversely related to health need. Although health-care
systems in high-income countries make extensive use of technology, people in the world's …

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

GS Cooke, I Andrieux-Meyer, TL Applegate… - The lancet …, 2019 - thelancet.com
Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual
mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV …